Clinical Trial Details
| Trial ID: | L1153 |
| Source ID: | NCT00907608 |
| Associated Drug: | Darbepoetin Alfa |
| Title: | A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic Nephropathy |
| Acronym: | |
| Status: | TERMINATED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus|Chronic Kidney Disease|Anemia |
| Interventions: | DRUG: Darbepoetin alfa |
| Outcome Measures: | Primary: Composite cardiovascular endpoint of myocardial infarction, congestive heart failure, arrhythmia, stroke, transient ischemic attack, amputation or ulceration / necrosis of lower limb, 3 years|Death, 3 years | Secondary: Doubling of mean serum creatinine, 3 years|50% reduction in mean estimated glomerular filtration rate during baseline period as estimated by the abbreviated Modification of Diet in Renal Disease equation, 3 years|Estimated glomerular filtration rate less than 15 mL/min/1.73m-2, 3 years|Change in fasting urinary albumin creatinine ratio, 3 years|Need for dialysis, 3 years|Number of hospital admissions, total number of days of hospital stay and attendance at the Accident and Emergency Department, 3 years |
| Sponsor/Collaborators: | Sponsor: Chinese University of Hong Kong |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | |
| Enrollment: | 16 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2007-12 |
| Completion Date: | 2009-05 |
| Results First Posted: | |
| Last Update Posted: | 2009-05-22 |
| Locations: | Prince of Wales Hospital, Hong Kong, China |
| URL: | https://clinicaltrials.gov/show/NCT00907608 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|